SLN Mapping and ICG Dye for Vulvar Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Vulva Cancer

Interventions

DRUG

Indocyanine green

Indocyanine green (ICG) is a fluorescent dye that has been used for the imaging of cancers in the body for more than 30 years.

Trial Locations (1)

Tufts Medical Center, Boston

All Listed Sponsors

lead

Tufts Medical Center

OTHER